patient schreef op 26 februari 2014 11:51:
[...]
Highlights
DSM reports final 2013 results, increases dividend
• 2013 FY EBITDA substantially up to €1,314 million (2012 FY: €1,109 million)
• Q4 2013 EBITDA €316 million (Q4 2012: €243 million)
• Strong cash generation from operating activities of €889 million in 2013
(2012: €730 million)
• Dividend increase of 10% proposed to €1.65 per ordinary share (2012: €1.50)
• Share repurchase program to hedge existing option plans continues
• Target for 2014 to improve business performance to at least offset negative
currency impact
Behalve verhoogd dividend gaat DSM ook gewon verder met inkoop aandelen